SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Neuland Laboratories informs about press release

04 Aug 2020 Evaluate

Neuland Laboratories has informed that the Company enclosed a copy of the Press Release being issued by the Company on 4th August 2020 titled ‘Neuland Q1FY21 income at Rs.206.1 crore; up 13.5%, EBITDA margins improve by 619 bps' along with Earnings PPT for the quarter ended June 30, 2020 and the same is being uploaded on the website of the Company.

The above information is a part of company’s filings submitted to BSE.

Neuland Laboratories Share Price

14998.70 346.20 (2.36%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.20
Dr. Reddys Lab 1322.95
Cipla 1309.90
Zydus Lifesciences 891.65
Lupin 2303.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×